F.‐D. T. Lung

A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells.

Masato Mutoh, F.‐D. T. Lung, Yong-jie Long et al. · PubMed · 1999 · 66 citations

Life Sciences, Molecular Biology, Oncology +14

Functional preference of the constituent amino acid residues in a phage‐library‐based nonphosphorylated inhibitor of the Grb2‐SH2 domain

F.‐D. T. Lung, Ya‐Qiu Long, Peter P. Roller et al. · Journal of Peptide Research · 2001 · 24 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Surface plasmon resonance detection of interactions between peptide fragments of N‐telopeptide and its monoclonal antibodies

F.‐D. T. Lung, C.‐H. Chen, C‐J Liou et al. · Journal of Peptide Research · 2004 · 13 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Novel peptide inhibitors for Grb2 SH2 domain and their detection by surface plasmon resonance

F.‐D. T. Lung, Jia‐Yin Tsai, Shu-Yie Wei et al. · Journal of Peptide Research · 2002 · 12 citations · Full text

Life Sciences, Biochemistry, Oncology +16